Skip to main content
Clinical and Translational Gastroenterology logoLink to Clinical and Translational Gastroenterology
. 2017 Oct 12;8(10):e122. doi: 10.1038/ctg.2017.50

Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease

Azade Amini Kadijani, Hamid Asadzadeh Aghdaei, Dario Sorrentino, Alireza Mirzaei, Shabnam Shahrokh, Hedieh Balaii, Vu Q Nguyen, Jessica L Mays, Mohammad Reza Zali
PMCID: PMC5666121  PMID: 29022926

Correction to: Clinical and Translational Gastroenterology (2017) 8:e117; doi:10.1038/ctg.2017.44. published online 14 September 2017

Table 2. Comparison of clinical and laboratory characteristics of IFX responders and non-responders as presented in the original publication was erroneously displayed. Although accurately discussed in the body of the manuscript, the values listed in Table 2—middle column were distorted to the left also shifting the subsequent values.

The error occurred during production and we regret any inconvenience that this inaccuracy may have caused. The error has been noted and corrected on the original manuscript.

The authors also discovered several corrections that were omitted during their review:

(1) Authors Shabnam Shahrokh and Hedieh Balaii should have been linked to Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

(2) In the footnote of Table 2, CDEIS has been explained as Crohn’s disease Index of Severity, while it should be Crohn’s disease Endoscopic Index of Severity.

(3) In Results section (page 4), the similarity of baseline CRP and FC has been repeated twice.

All of these corrections have been made to the published version of the paper.


Articles from Clinical and Translational Gastroenterology are provided here courtesy of American College of Gastroenterology

RESOURCES